Literature DB >> 24845249

Development and progress of Ireland's biobank network: Ethical, legal, and social implications (ELSI), standardized documentation, sample and data release, and international perspective.

Blanaid Mee1, Eoin Gaffney, Sharon A Glynn, Simona Donatello, Paul Carroll, Elizabeth Connolly, Sarah Mc Garrigle, Terry Boyle, Delia Flannery, Francis J Sullivan, Paul McCormick, Mairead Griffin, Cian Muldoon, Joanna Fay, Tony O'Grady, Elaine Kay, Joe Eustace, Louise Burke, Asim A Sheikh, Stephen Finn, Richard Flavin, Francis J Giles.   

Abstract

Biobank Ireland Trust (BIT) was established in 2004 to promote and develop an Irish biobank network to benefit patients, researchers, industry, and the economy. The network commenced in 2008 with two hospital biobanks and currently consists of biobanks in the four main cancer hospitals in Ireland. The St. James's Hospital (SJH) Biobank coordinates the network. Procedures, based on ISBER and NCI guidelines, are standardized across the network. Policies and documents-Patient Consent Policy, Patient Information Sheet, Biobank Consent Form, Sample and Data Access Policy (SAP), and Sample Application Form have been agreed upon (after robust discussion) for use in each hospital. An optimum sequence for document preparation and submission for review is outlined. Once consensus is reached among the participating biobanks, the SJH biobank liaises with the Research and Ethics Committees, the Office of the Data Protection Commissioner, The National Cancer Registry (NCR), patient advocate groups, researchers, and other stakeholders. The NCR provides de-identified data from its database for researchers via unique biobank codes. ELSI issues discussed include the introduction of prospective consent across the network and the return of significant research results to patients. Only 4 of 363 patients opted to be re-contacted and re-consented on each occasion that their samples are included in a new project. It was decided, after multidisciplinary discussion, that results will not be returned to patients. The SAP is modeled on those of several international networks. Biobank Ireland is affiliated with international biobanking groups-Marble Arch International Working Group, ISBER, and ESBB. The Irish government continues to deliberate on how to fund and implement biobanking nationally. Meanwhile BIT uses every opportunity to promote awareness of the benefits of biobanking in events and in the media.

Entities:  

Mesh:

Year:  2013        PMID: 24845249      PMCID: PMC4076973          DOI: 10.1089/bio.2012.0028

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  25 in total

1.  The impact of the organ retention controversy on the practice of hospital necropsy: a four year audit.

Authors:  D McGuone; E W Kay
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

Review 2.  Expanding the ethical analysis of biobanks.

Authors:  Mark A Rothstein
Journal:  J Law Med Ethics       Date:  2005       Impact factor: 1.718

Review 3.  To know the value of everything--a critical commentary on B Björkman and S O Hansson's "Bodily rights and property rights".

Authors:  J R Karlsen; P L de Faria; J H Solbakk
Journal:  J Med Ethics       Date:  2006-04       Impact factor: 2.903

4.  Informed consent and biobanks.

Authors:  Ellen Wright Clayton
Journal:  J Law Med Ethics       Date:  2005       Impact factor: 1.718

5.  Disclosing genetic research results: examples from practice.

Authors:  Kelly E Ormond
Journal:  Am J Bioeth       Date:  2006 Nov-Dec       Impact factor: 11.229

6.  The human face of biobank networks for translational research.

Authors:  Karen Meir; Eoin F Gaffney; Daniel Simeon-Dubach; Rivka Ravid; Peter H Watson; Brent Schacter; Manuel M Morente And The Marble Arch International Working Group On Biobanking
Journal:  Biopreserv Biobank       Date:  2011-09       Impact factor: 2.300

7.  Biobanks need publicity.

Authors:  George Gaskell; Herbert Gottweis
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

8.  A review of international biobanks and networks: success factors and key benchmarks.

Authors:  Jim Vaught; Andrea Kelly; Robert Hewitt
Journal:  Biopreserv Biobank       Date:  2010-03-17       Impact factor: 2.300

9.  Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer.

Authors:  Paul A Carroll; Laura Healy; Joanne Lysaght; Terry Boyle; John V Reynolds; M John Kennedy; Graham Pidgeon; Elizabeth M Connolly
Journal:  Mol Carcinog       Date:  2011-05-13       Impact factor: 4.784

10.  Trends in ethical and legal frameworks for the use of human biobanks.

Authors:  A Cambon-Thomsen; E Rial-Sebbag; B M Knoppers
Journal:  Eur Respir J       Date:  2007-08       Impact factor: 16.671

View more
  6 in total

1.  Assessing Researcher Needs for a Virtual Biobank.

Authors:  Jenna van Draanen; Pamela Davidson; Helene Bour-Jordan; LeeAnna Bowman-Carpio; David Boyle; Steve Dubinett; Brian Gardner; Jachael Gardner; Courtney McFall; Dan Mercola; Terry Nakazono; Stephanie Soares; Hubert Stoppler; Margaret Tempero; Scott Vandenberg; Yu Jui Wan; Sarah Dry
Journal:  Biopreserv Biobank       Date:  2016-12-08       Impact factor: 2.300

2.  Returning Results: Let's Be Honest!

Authors:  Bernice S Elger; Eva De Clercq
Journal:  Genet Test Mol Biomarkers       Date:  2017-02-24

Review 3.  Ethical implications of using biobanks and population databases for genetic suicide research.

Authors:  Jess Shade; Hilary Coon; Anna R Docherty
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-18       Impact factor: 3.568

4.  Study protocol for the St James's Hospital, Tallaght University Hospital, Trinity College Dublin Allied Researchers' (STTAR) Bioresource for COVID-19.

Authors:  Laura O'Doherty; Stuart Hendricken Phelan; Nicole Wood; Sorcha O'Brien; Jacklyn Sui; Cian Mangan; Fergal Howley; Siobhan O'Regan; Noor Adeebah Mohamed Razif; Ciara Conlan; Ruth Argue; Samuel Holohan; Adam Dyer; Fara Salleh; Liam Townsend; Gerard Hughes; Colm Kerr; Derval Reidy; Alberto Sanz; Emma Connolly; Andrea Kelly; Emma Leacy; Conor Reddy; Siobhan Gargan; Eamon Breen; Heike Hawerkamp; Jean Dunne; Ignacio Martin-Loeches; Anne Marie McLaughlin; Aideen Long; Orla Shiels; Padraic Fallon; Martina Hennessy; Roman Romero-Ortuno; Ciaran Bannan; Anna Rose Prior; Ana Rakovac; William McCormack; Ross McManus; Seamus Donnelly; Colm Bergin; Mark Little; Clíona Ní Cheallaigh; Niall Conlon
Journal:  HRB Open Res       Date:  2022-03-16

5.  EPMA position paper in cancer: current overview and future perspectives.

Authors:  Godfrey Grech; Xianquan Zhan; Byong Chul Yoo; Rostyslav Bubnov; Suzanne Hagan; Romano Danesi; Giorgio Vittadini; Dominic M Desiderio
Journal:  EPMA J       Date:  2015-04-15       Impact factor: 6.543

6.  What GDPR and the Health Research Regulations (HRRs) mean for Ireland: a research perspective.

Authors:  Blanaid Mee; Mary Kirwan; Niamh Clarke; Aoife Tanaka; Lino Manaloto; Emma Halpin; Una Gibbons; Ann Cullen; Sarah McGarrigle; Elisabeth M Connolly; Kathleen Bennett; Eoin Gaffney; Ciaran Flanagan; Laura Tier; Richard Flavin; Noel G McElvaney
Journal:  Ir J Med Sci       Date:  2020-07-29       Impact factor: 1.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.